WHERE DOES NEWS ABOUT PRESCRIPTION DRUGS COME FROM?: EXPLORING HOW ORGANIZATIONS BUILT AND FRAMED THE NATIONAL NEWS MEDIA AGENDA FOR HORMONE THERAPY FROM 1995 TO 2011

Simple item page
dc.contributor.advisorAldoory, Lindaen_US
dc.contributor.authorWeissman, Paula L.en_US
dc.contributor.departmentCommunicationen_US
dc.contributor.publisherDigital Repository at the University of Marylanden_US
dc.contributor.publisherUniversity of Maryland (College Park, Md.)en_US
dc.date.accessioned2013-06-28T05:52:31Z
dc.date.available2013-06-28T05:52:31Z
dc.date.issued2013en_US
dc.description.abstractABSTRACT This longitudinal study explored how health and medical organizations used public relations techniques to influence news content about postmenopausal hormone therapy (HT) from 1995 to 2011. A theoretical framework that combined agenda building, information subsidies, and framing guided the study (Zoch & Molleda, 2006). Quantitative content analyses were conducted on 675 press releases about HT distributed through PR Newswire and EurekAlert!, and 429 news stories about HT in the Associated Press Newswire (AP), The New York Times, The Washington Post, Los Angeles Times, and The Wall Street Journal. Supplemental qualitative content analyses of organizational websites, annual reports, and scientific publications explored financial relationships and potential collaborations between ten organizations that emerged as the most successful agenda builders. Six types of health and medical organizations produced press releases about HT: pharmaceutical companies, academic/medical institutions, nonprofit health advocacy organizations, medical/scientific journal publishers, U.S. government agencies, and other for-profit organizations. A positive, statistically significant relationship was found between the quantity of press releases and news stories over time (r = .55, p<.001). Findings also supported the transference of specific objects, such as brand-name HT products, and attributes, such as risks and benefits, from the public relations to the news media agenda. Academic/medical institutions and nonprofit health advocacy organizations were significantly more likely than pharmaceutical companies to identify non-FDA approved, "off-label" benefits. Wyeth Pharmaceuticals, manufacturer of leading HT brands Premarin and Prempro, financially subsidized most of the top-ten, agenda-building organizations, including four academic/medical institutions and two non-profit health advocacy organizations that were frequently cited in news stories. Additionally, a substantial degree of synergy was found between these organizations in terms of how they framed menopause and HT over the study period. This study supported and extended the theoretical framework used by offering insights into how organizations may collaborate through funding arrangements and third-party communication techniques to influence news content in a health and medical context. The findings also contributed a new and important dimension to scholarship on pharmaceutical promotion of prescription drugs, which has neglected the role of public relations and focused almost exclusively on more overt, paid-promotional efforts like direct-to-consumer advertising.en_US
dc.identifier.urihttp://hdl.handle.net/1903/14009
dc.subject.pqcontrolledCommunicationen_US
dc.subject.pqcontrolledMass communicationen_US
dc.subject.pquncontrolledagenda buildingen_US
dc.subject.pquncontrolledframingen_US
dc.subject.pquncontrolledhormone therapyen_US
dc.subject.pquncontrollednews mediaen_US
dc.subject.pquncontrolledprescription drugsen_US
dc.subject.pquncontrolledpublic relationsen_US
dc.titleWHERE DOES NEWS ABOUT PRESCRIPTION DRUGS COME FROM?: EXPLORING HOW ORGANIZATIONS BUILT AND FRAMED THE NATIONAL NEWS MEDIA AGENDA FOR HORMONE THERAPY FROM 1995 TO 2011en_US
dc.typeDissertationen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Weissman_umd_0117E_14047.pdf
Size:
2.28 MB
Format:
Adobe Portable Document Format
Download

Collections

UMD Theses and Dissertations
Communication Theses and Dissertations